Twist Bioscience Corporation Common Stock — gráfico, cotizaciones y noticias (NASDAQ:TWST)

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Trimestre Año

Market Capitalization 3.46 B
Employee 979
Founded 2013
CEO Emily LeProust
Website www.twistbioscience.com
Headquarter Delaware, United States
FIGI BBG006KDCHJ4
Industry Technology

Ingresos totales

Beneficio neto

Beneficio básico por acción

Deuda total

Flujo de caja libre

Efectivo y equivalentes

3.46 B Capitalización de mercado

Ratio precio/beneficio

-21.65

Relación precio/flujo de caja

4.47

Twist Bioscience Corporation

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.